These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31582843)

  • 1. Chromatin engineering offers an opportunity to advance epigenetic cancer therapy.
    Baskin NL; Haynes KA
    Nat Struct Mol Biol; 2019 Oct; 26(10):842-845. PubMed ID: 31582843
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic Regulation and Drug Discovery for Cancer Therapy.
    Yu B; Ouyang L
    Curr Top Med Chem; 2019; 19(12):971. PubMed ID: 31486748
    [No Abstract]   [Full Text] [Related]  

  • 3. Epigenetic opportunities and challenges in cancer.
    Best JD; Carey N
    Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting chromatin.
    Nat Struct Mol Biol; 2019 Oct; 26(10):841. PubMed ID: 31582845
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthetic lethal vulnerabilities of cancer.
    Fece de la Cruz F; Gapp BV; Nijman SM
    Annu Rev Pharmacol Toxicol; 2015; 55():513-31. PubMed ID: 25340932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
    Bayo J; Dalvi MP; Martinez ED
    Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Epigenetics in Cancer.
    Bennett RL; Licht JD
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():187-207. PubMed ID: 28992434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic agents in combined anticancer therapy.
    Kejík Z; Jakubek M; Kaplánek R; Králová J; Mikula I; Martásek P; Král V
    Future Med Chem; 2018 May; 10(9):1113-1130. PubMed ID: 29676175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting components of epigenome by small molecules.
    You JS; Han JH
    Arch Pharm Res; 2014 Nov; 37(11):1367-74. PubMed ID: 25070764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic cancer therapy makes headway.
    Mack GS
    J Natl Cancer Inst; 2006 Oct; 98(20):1443-4. PubMed ID: 17047192
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer.
    Verma SK; Knight SD
    Future Med Chem; 2013 Sep; 5(14):1661-70. PubMed ID: 24047271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-bound enzymes as epigenetic drug targets in cancer.
    Bomsztyk K; Wang Y
    Epigenomics; 2019 Oct; 11(13):1463-1467. PubMed ID: 31536377
    [No Abstract]   [Full Text] [Related]  

  • 15. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodomain biology and drug discovery.
    Zaware N; Zhou MM
    Nat Struct Mol Biol; 2019 Oct; 26(10):870-879. PubMed ID: 31582847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small Molecular Inhibitors Targeting Chromatin Regulating Proteins for Cancer.
    Luan J; Chu Z; Chandra J; Zhang P
    Curr Protein Pept Sci; 2016; 17(5):455-62. PubMed ID: 26796303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopping a chromatin enzyme.
    Simon JA
    Nat Chem Biol; 2012 Nov; 8(11):875-6. PubMed ID: 23076065
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting the epigenetic regulation of antitumour immunity.
    Hogg SJ; Beavis PA; Dawson MA; Johnstone RW
    Nat Rev Drug Discov; 2020 Nov; 19(11):776-800. PubMed ID: 32929243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.
    Raynal NJ; Da Costa EM; Lee JT; Gharibyan V; Ahmed S; Zhang H; Sato T; Malouf GG; Issa JJ
    Mol Cancer Ther; 2017 Feb; 16(2):397-407. PubMed ID: 27980103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.